Cargando…
Corrigendum: High expression of PARP1 in tumor and stroma cells predicts prognosis and platinum resistance in patients with advanced epithelial ovarian cancer
Autores principales: | Zuo, Wei-Wei, Zhao, Chun-Fang, Li, Yan, Sun, Hai-Yan, Ma, Guo-Ming, Liu, Yue-Ping, Kang, Shan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338329/ https://www.ncbi.nlm.nih.gov/pubmed/37456252 http://dx.doi.org/10.3389/fonc.2023.1218746 |
Ejemplares similares
-
High Expression of PARP1 in Tumor and Stroma Cells Predicts Different Prognosis and Platinum Resistance in Patients With Advanced Epithelial Ovarian Cancer
por: Zuo, Wei-Wei, et al.
Publicado: (2022) -
Evaluation of the Efficacy and Safety of PARP Inhibitors in Advanced-Stage Epithelial Ovarian Cancer
por: Jiang, Yifan, et al.
Publicado: (2020) -
Corrigendum: Biomarking and induction of apoptosis in ovarian cancer using bifunctional polyethyleneimine-caged platinum nanoclusters
por: Zhang, Mengjun, et al.
Publicado: (2022) -
Efficacy and Prognostic Factors for PARP Inhibitors in Patients With Ovarian Cancer
por: Huang, Xuan-zhang, et al.
Publicado: (2020) -
The Role of the Tumor Stroma in Ovarian Cancer
por: Davidson, Ben, et al.
Publicado: (2014)